Back to News
Market Impact: 0.38

lululemon Pre-Q1 Earnings: Is it the Right Time to Buy the Stock?

LULUVFCRLPVHMSFTGOOGLAMZNORCLMETATSLANVDA
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesConsumer Demand & RetailCompany FundamentalsTax & TariffsTrade Policy & Supply ChainManagement & GovernanceProduct Launches
lululemon Pre-Q1 Earnings: Is it the Right Time to Buy the Stock?

lululemon is expected to report fiscal Q1 2026 revenue of about $2.4 billion, up 2.6% year over year, but EPS is projected to fall 35.8% to $1.67. Management guided to 1-3% revenue growth, with North America sales down in the mid-single digits and gross margin pressured by tariffs, markdowns, and SG&A deleverage of 330 bps; operating margin is expected to contract 710 bps. The setup is cautious, with strong China growth and brand momentum offset by weak U.S. demand and ongoing margin pressure.

Analysis

The setup is less about a single earnings print and more about whether LULU can convince the market that North America is a temporary air pocket rather than the start of a multi-quarter growth stall. The risk is that margin compression is becoming self-reinforcing: more promotional intensity to move inventory suppresses gross margin, which then forces tighter opex discipline, which can slow brand investment and worsen traffic. If management sounds defensive on U.S. women’s, the stock likely trades on the next 2-3 quarters of estimate revisions rather than on Q1 itself. The second-order winner is not another premium athleisure brand so much as off-price and broadline apparel channels that can absorb clearance flow and benefit from a more promotional category backdrop. For direct competitors, weaker LULU full-price conversion raises the bar for everyone in premium activewear; if consumers are trading down, the damage can spread to adjacent discretionary names with similar ASPs and lower price elasticity. International strength, especially China, matters more than the headline because it can mask a deteriorating U.S. mix, but it also creates a valuation trap if investors over-apply that growth rate to a lower-quality consolidated margin profile. The contrarian read is that the market may already be discounting a lot of bad news: the stock’s de-rating leaves room for a relief rally if gross margin and North America comps come in only slightly better than feared. The real catalyst would be evidence that markdowns peaked in Q1 and that product refresh is restoring full-price sell-through by late summer; that would shift the debate from cyclical slowdown to recoverability. Absent that, the stock likely remains a show-me story with better reward on post-print volatility than on outright direction.